S&P 500   4,225.46 (-1.47%)
DOW   32,973.01 (-1.38%)
QQQ   353.92 (-2.03%)
AAPL   172.13 (-0.93%)
MSFT   312.28 (-2.96%)
META   300.07 (-2.20%)
GOOGL   132.09 (-1.55%)
AMZN   124.63 (-3.73%)
TSLA   246.26 (-2.12%)
NVDA   435.02 (-2.86%)
NIO   8.67 (-1.37%)
BABA   84.51 (-2.33%)
AMD   99.60 (-3.55%)
T   14.79 (+0.82%)
F   12.11 (-1.62%)
MU   67.62 (-0.50%)
CGC   0.68 (-7.41%)
GE   107.79 (-0.92%)
DIS   79.61 (-2.52%)
AMC   7.93 (-2.70%)
PFE   33.93 (-0.03%)
PYPL   57.29 (-2.17%)
NFLX   375.12 (-1.37%)
S&P 500   4,225.46 (-1.47%)
DOW   32,973.01 (-1.38%)
QQQ   353.92 (-2.03%)
AAPL   172.13 (-0.93%)
MSFT   312.28 (-2.96%)
META   300.07 (-2.20%)
GOOGL   132.09 (-1.55%)
AMZN   124.63 (-3.73%)
TSLA   246.26 (-2.12%)
NVDA   435.02 (-2.86%)
NIO   8.67 (-1.37%)
BABA   84.51 (-2.33%)
AMD   99.60 (-3.55%)
T   14.79 (+0.82%)
F   12.11 (-1.62%)
MU   67.62 (-0.50%)
CGC   0.68 (-7.41%)
GE   107.79 (-0.92%)
DIS   79.61 (-2.52%)
AMC   7.93 (-2.70%)
PFE   33.93 (-0.03%)
PYPL   57.29 (-2.17%)
NFLX   375.12 (-1.37%)
S&P 500   4,225.46 (-1.47%)
DOW   32,973.01 (-1.38%)
QQQ   353.92 (-2.03%)
AAPL   172.13 (-0.93%)
MSFT   312.28 (-2.96%)
META   300.07 (-2.20%)
GOOGL   132.09 (-1.55%)
AMZN   124.63 (-3.73%)
TSLA   246.26 (-2.12%)
NVDA   435.02 (-2.86%)
NIO   8.67 (-1.37%)
BABA   84.51 (-2.33%)
AMD   99.60 (-3.55%)
T   14.79 (+0.82%)
F   12.11 (-1.62%)
MU   67.62 (-0.50%)
CGC   0.68 (-7.41%)
GE   107.79 (-0.92%)
DIS   79.61 (-2.52%)
AMC   7.93 (-2.70%)
PFE   33.93 (-0.03%)
PYPL   57.29 (-2.17%)
NFLX   375.12 (-1.37%)
S&P 500   4,225.46 (-1.47%)
DOW   32,973.01 (-1.38%)
QQQ   353.92 (-2.03%)
AAPL   172.13 (-0.93%)
MSFT   312.28 (-2.96%)
META   300.07 (-2.20%)
GOOGL   132.09 (-1.55%)
AMZN   124.63 (-3.73%)
TSLA   246.26 (-2.12%)
NVDA   435.02 (-2.86%)
NIO   8.67 (-1.37%)
BABA   84.51 (-2.33%)
AMD   99.60 (-3.55%)
T   14.79 (+0.82%)
F   12.11 (-1.62%)
MU   67.62 (-0.50%)
CGC   0.68 (-7.41%)
GE   107.79 (-0.92%)
DIS   79.61 (-2.52%)
AMC   7.93 (-2.70%)
PFE   33.93 (-0.03%)
PYPL   57.29 (-2.17%)
NFLX   375.12 (-1.37%)
NASDAQ:KRBP

Kiromic BioPharma (KRBP) News Today

$0.22
-0.07 (-24.10%)
(As of 11:15 AM ET)
Compare
Today's Range
$0.22
▼
$0.22
50-Day Range
$0.29
▼
$2.65
52-Week Range
$0.22
▼
$15.30
Volume
1,877 shs
Average Volume
167,585 shs
Market Capitalization
$259,718.00
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
ProfileChartCompetitorsEarningsFinancialsInstitutional OwnershipHeadlinesSEC FilingsShort InterestSocial Media
SourceHeadline
uk.investing.com logoStaidson Beijing Biopharma (300204)
uk.investing.com - September 15 at 9:22 PM
finance.yahoo.com logoKiromic BioPharma Common Stock to Begin Trading on the OTC Pink Sheets on September 14
finance.yahoo.com - September 13 at 7:00 PM
finance.yahoo.com logoKiromic BioPharma Welcomes Two New Directors to its Board
finance.yahoo.com - July 24 at 3:55 PM
marketbeat.com logo
marketbeat.com - July 12 at 9:59 AM
marketbeat.com logo
marketbeat.com - July 12 at 9:49 AM
marketwatch.com logoKiromic Biopharma Shares Down 12% After Stock Offering Prospectus
marketwatch.com - June 30 at 2:18 PM
bizjournals.com logoFounder of multibillion-dollar drug developer Array BioPharma leads Boulder oncology startup in $54M financing round
bizjournals.com - June 10 at 11:45 PM
finance.yahoo.com logoKRBP - Kiromic BioPharma, Inc.
finance.yahoo.com - June 10 at 1:42 PM
theglobeandmail.com logoInstrument Name Kiromic Biopharma Inc Instrument Symbol (KRBP-Q)
theglobeandmail.com - June 8 at 7:49 AM
marketbeat.com logo
marketbeat.com - May 22 at 12:50 PM
marketbeat.com logo
marketbeat.com - May 10 at 1:13 PM
marketbeat.com logo
marketbeat.com - May 8 at 3:15 PM
marketbeat.com logo
marketbeat.com - May 8 at 2:15 PM
marketbeat.com logo
marketbeat.com - May 4 at 11:10 AM
finance.yahoo.com logoWhat's Going On With Kiromic BioPharma Stock Wednesday
finance.yahoo.com - May 3 at 7:03 PM
marketbeat.com logo
marketbeat.com - May 3 at 3:14 PM
marketbeat.com logo
marketbeat.com - May 3 at 11:38 AM
marketbeat.com logo
marketbeat.com - May 3 at 11:25 AM
marketbeat.com logo
marketbeat.com - May 3 at 10:52 AM
marketbeat.com logo
marketbeat.com - May 3 at 10:44 AM
marketbeat.com logo
marketbeat.com - May 3 at 10:41 AM
marketbeat.com logo
marketbeat.com - May 3 at 10:28 AM
marketbeat.com logo
marketbeat.com - May 3 at 10:19 AM
marketbeat.com logo
marketbeat.com - May 3 at 9:43 AM
finance.yahoo.com logoKiromic BioPharma Announces FDA Authorization of IND to Initiate Phase 1 Clinical Trial Evaluating Deltacel in Non-Small Cell Lung Cancer
finance.yahoo.com - May 1 at 1:04 PM
marketbeat.com logo
marketbeat.com - April 17 at 9:39 AM
marketbeat.com logo
marketbeat.com - April 13 at 10:43 AM
finance.yahoo.com logoKiromic BioPharma Submits Investigational New Drug Application for Phase 1 Trial with Deltacel for Non-Small Cell Lung Cancer
finance.yahoo.com - April 3 at 9:39 AM
marketbeat.com logo
marketbeat.com - March 31 at 10:28 AM
finance.yahoo.com logoKiromic BioPharma Announces Reverse Stock Split
finance.yahoo.com - March 10 at 8:40 PM
finance.yahoo.com logoKiromic BioPharma Reports Favorable Deltacel™ Preclinical Pharmacology Results
finance.yahoo.com - February 28 at 9:28 AM
finance.yahoo.com logoTwo Leading Independent Proxy Advisory Firms Recommend Kiromic BioPharma Stockholders Vote "FOR" All Proxy Proposals
finance.yahoo.com - February 23 at 5:24 PM
msn.com logoKiromic BioPharma CEO encourages stock split, sees Deltacel trial in 2Q23
msn.com - February 16 at 4:55 PM
finance.yahoo.com logoKiromic BioPharma CEO Issues Letter to Stockholders
finance.yahoo.com - February 16 at 11:55 AM
yahoo.com logoCambrian BioPharma Unveils New Pipeline Company - Isterian Biotech
yahoo.com - January 15 at 12:59 AM
seekingalpha.com logoCTI BioPharma: Checking Back In
seekingalpha.com - January 15 at 12:59 AM
finance.yahoo.com logoKiromic BioPharma Arranges Up to $10 Million Financing
finance.yahoo.com - October 27 at 7:28 PM
finance.yahoo.com logoKiromic Shares Surge After Streamlining Operations To Execute Deltacel-Aligned Development Strategy
finance.yahoo.com - October 14 at 1:51 AM
finance.yahoo.com logoKiromic BioPharma Announces FDA Feedback from Type B Pre-IND Meeting Confirms Deltacel Development Strategy
finance.yahoo.com - October 6 at 1:07 PM
marketwatch.com logoHAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Alerts Kiromic BioPharma (KRBP) Investors with Losses to Lead Plaintiff Deadline in Securities Class Action
marketwatch.com - October 6 at 3:07 AM
stockhouse.com logoDEADLINE TOMORROW: The Schall Law Firm Encourages Investors in Kiromic BioPharma, Inc. with Losses of $100,000 to Contact the Firm
stockhouse.com - October 5 at 5:06 PM
theglobeandmail.com logoKiromic BioPharma: Top 10 Undervalued Healthcare Stocks on NAS (KRBP)
theglobeandmail.com - October 5 at 5:06 PM
benzinga.com logoFINAL DEADLINE ALERT: The Schall Law Firm Encourages Investors in Kiromic BioPharma, Inc. with Losses of $100,000 to Contact the Firm
benzinga.com - October 4 at 4:03 PM
benzinga.com logoHagens Berman, National Trial Attorneys, Announces It Has Filed A Class Action Lawsuit Against Kiromic BioPharma (KRBP)
benzinga.com - October 4 at 5:39 AM
benzinga.com logoFinal Deadline Alert: Bronstein, Gewirtz & Grossman, LLC Notifies Kiromic BioPharma, Inc. (KRBP) Investors of Class Action and to Actively Participate
benzinga.com - October 3 at 1:26 PM
prnewswire.com logoKRBP Shareholder Reminder: Kessler Topaz Meltzer & Check, LLP Reminds Shareholders of Kiromic BioPharma, Inc. of Deadline in Securities Fraud Class Action Lawsuit
prnewswire.com - October 2 at 2:26 PM
benzinga.com logoDeadline in 3 Days: Kessler Topaz Meltzer & Check, LLP Reminds Kiromic BioPharma, Inc. (KRBP) Investors of Filing Deadline in Class Action Lawsuit
benzinga.com - October 1 at 11:10 AM
prnewswire.com logoKRBP DEADLINE REMINDER: Kessler Topaz Meltzer & Check, LLP - Important October 4, 2022 Deadline Reminder for Kiromic BioPharma, Inc.
prnewswire.com - September 24 at 4:39 PM
marketbeat.com logo
marketbeat.com - September 23 at 9:39 AM
prnewswire.com logoKRBP LAWSUIT ALERT: Levi & Korsinsky Notifies Kiromic BioPharma, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline
prnewswire.com - September 22 at 6:11 AM
Get Kiromic BioPharma News Delivered to You Automatically

Sign up to receive the latest news and ratings for KRBP and its competitors with MarketBeat's FREE daily newsletter.



KRBP Media Mentions By Week

KRBP Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

KRBP
News Sentiment
▼
0.00

0.70
▲
Average
Medical
News Sentiment

KRBP News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

KRBP Articles
This Week
▼
0

0
▲
KRBP Articles
Average Week

Get Kiromic BioPharma News Delivered to You Automatically

Sign up to receive the latest news and ratings for KRBP and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools

Related Companies:
Headlines Tools:
This page (NASDAQ:KRBP) was last updated on 10/3/2023 by MarketBeat.com Staff

My Account -